在慢性血液透析患者中,他类药物的可溶性和死亡率之间的相关性
Seok-Hui Kang1, Gui-Ok Kim2, Bo-Yeon Kim3
1Division of Nephrology, Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea.
Diagnostics (Basel, Switzerland)
|October 28, 2023
概括
脂友性他类药物可以改善血液透析患者的存活率. 这项研究发现,与不服用他类药物的患者相比,服用他类药物的患者的生存益处很小.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
背景情况:
- 接受血液透析 (HD) 的患者面临心血管疾病风险增加.
- 类药物通常被处方用于管理这种人群中的失脂症.
- 类药物溶解度对HD患者结局的影响尚未得到充分证实.
研究的目的:
- 评估他类药物溶解度对血液透析患者存活率的影响.
- 为了比较服用脂友性他类药物,水友性他类药物和不服用他类药物的患者之间的生存率.
主要方法:
- 来自国家疾病的质量评估计划 (n=53,345) 的实验室,临床和索赔数据的回顾性分析.
- 根据处方数据,患者被分为"不使用他类药物"",水性他类药物"和"脂性他类药物"组.
- 使用多变量考克斯回归分析的5年生存率,与子组分析.
主要成果:
- 整体5年生存率为69.6% (No),67.9% (Hydro) 和67.9% (Lipo) 的情况.
- 在多变量分析中,与不使用他类药物相比,脂友性他类药物的使用与更好的患者存活率有关.
- 水友性和脂友性他类药物组之间,或水友性和没有他类药物组之间没有发现显著的生存差异.
结论:
- 与没有使用他类药物相比,脂友性他类药物在血液透析患者中显示出适度的生存益处.
- 在水友性他类药物的情况下,他类药物的溶解性没有显著影响生存率.
- 进一步的研究可能会澄清特定类型的他类药物在改善HD患者治疗结果中的作用.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
676
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
676
01:11Renal Failure: Dose Adjustments
97
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
97
01:24Hemodialysis II: Procedure and Complications
27
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
27
01:25Hemodialysis III: Nursing Management
25
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
25
01:09Hepatic Drug Clearance: Effect of Protein Binding
216
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
216
01:22Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
181
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
181